MG
INFU icon

Michael Gelband’s InfuSystem Holdings INFU Stock Holding History

Michael Gelband’s Portfolio INFU Stock Details INFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,008
Closed -$404K – 1807
2025
Q4 		$404K Buy
+45,008
New +$431K ﹤0.01% 1227
2020
Q1 		– Sell
-33,187
Closed -$283K – 1343
2019
Q4 		$283K Buy
+33,187
New +$244K 0.01% 1169

Other funds holding INFU

MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Michael Gelband's INFU Position: Q1 2026 in Review

Michael Gelband sold out of InfuSystem Holdings (INFU) in Q1 2026, closing a stake of 45,008 shares — an estimated $404K sold.

Michael Gelband first reported a position in INFU in Q4 2019 and held it in 2 quarters. The position peaked at $404K in Q4 2025. 96 funds tracked by Wall St. Rank hold INFU as of Q1 2026.

  • Michael Gelband reported no remaining InfuSystem Holdings position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 45,008 InfuSystem Holdings shares in Q1 2026, an estimated $404K.
  • Michael Gelband first reported a position in InfuSystem Holdings in Q4 2019 and held it in 2 quarters.
  • Michael Gelband's InfuSystem Holdings position peaked at $404K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.